Sanofi (SNY) Receivables - Net (2016 - 2024)
Historic Receivables - Net for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $8.8 billion.
- Sanofi's Receivables - Net fell 353.23% to $8.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8.8 billion, marking a year-over-year decrease of 353.23%. This contributed to the annual value of $8.2 billion for FY2024, which is 1006.91% down from last year.
- As of Q2 2025, Sanofi's Receivables - Net stood at $8.8 billion, which was down 353.23% from $8.2 billion recorded in Q4 2024.
- Sanofi's 5-year Receivables - Net high stood at $9.2 billion for Q2 2024, and its period low was $8.2 billion during Q2 2021.
- Over the past 5 years, Sanofi's median Receivables - Net value was $8.7 billion (recorded in 2021), while the average stood at $8.7 billion.
- Its Receivables - Net has fluctuated over the past 5 years, first soared by 750.98% in 2023, then crashed by 958.62% in 2024.
- Sanofi's Receivables - Net (Quarter) stood at $8.7 billion in 2021, then dropped by 0.73% to $8.6 billion in 2022, then increased by 5.57% to $9.1 billion in 2023, then fell by 9.59% to $8.2 billion in 2024, then rose by 7.76% to $8.8 billion in 2025.
- Its last three reported values are $8.8 billion in Q2 2025, $8.2 billion for Q4 2024, and $9.2 billion during Q2 2024.